Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 5 May 23 424B4 Prospectus supplement with pricing info
- 5 May 23 EFFECT Notice of effectiveness
- 3 May 23 S-1/A IPO registration (amended)
-
1 May 23 S-1/A IPO registration (amended)
- 13 Apr 23 S-1 IPO registration
SLRN similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1 of ACELYRIN, INC. of our report dated March 24, 2023 relating to the financial statements of ValenzaBio, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
San Diego, California
May 1, 2023